{"id":18752,"date":"2016-02-03T13:54:25","date_gmt":"2016-02-03T12:54:25","guid":{"rendered":"http:\/\/blog.cofb.cat\/?p=18752"},"modified":"2016-02-03T13:54:25","modified_gmt":"2016-02-03T12:54:25","slug":"cap-a-una-millor-gestio-del-dolor-cronic-oncologic","status":"publish","type":"post","link":"https:\/\/www.cofb.org\/ca\/2016\/02\/03\/cap-a-una-millor-gestio-del-dolor-cronic-oncologic\/","title":{"rendered":"Cap a una millor gesti\u00f3 del dolor cr\u00f2nic no oncol\u00f2gic"},"content":{"rendered":"<p>El dolor est\u00e0 entre els primers trastorns cr\u00f2nics declarats per la poblaci\u00f3, amb afectaci\u00f3 important de la qualitat de vida de les persones que el pateixen. La prevalen\u00e7a del dolor cr\u00f2nic en la poblaci\u00f3 adulta a l\u2019estat espanyol \u00e9s del 23,4% i superior en les dones i en el grup de m\u00e9s edat. <b>El dolor \u00e9s un s\u00edmptoma que \u00e9s present en moltes malalties<\/b> i, per tant, <b>les propostes per millorar-ne la gesti\u00f3 s\u00f3n objectius dels diferents professionals sanitaris en l\u2019atenci\u00f3 prim\u00e0ria i especialitzada<\/b> que intervenen en l\u2019estrat\u00e8gia del tractament per millorar la qualitat de l\u2019atenci\u00f3 als pacients amb dolor, de vegades, dolor cr\u00f2nic complex o de dif\u00edcil tractament. D\u2019altra banda, el dolor cr\u00f2nic t\u00e9 uns costos associats importants tant per l\u2019increment de la utilitzaci\u00f3 de serveis sanitaris com per l\u2019augment de la prescripci\u00f3 de f\u00e0rmacs i per la p\u00e8rdua de dies de treball. \u00c9s per aix\u00f2 que es feia convenient fer una revisi\u00f3 de les estrat\u00e8gies de tractament i de la gesti\u00f3 cl\u00ednica del pacient.<\/p>\n<figure id=\"attachment_18757\" aria-describedby=\"caption-attachment-18757\" style=\"width: 298px\" class=\"wp-caption alignright\"><a href=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2016\/01\/curs-dolor-cronic-no-oncologic-3.jpg\"><img fetchpriority=\"high\" decoding=\"async\" class=\" wp-image-18757  \" alt=\"curs-dolor-cronic-no-oncologic (3)\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2016\/01\/curs-dolor-cronic-no-oncologic-3.jpg\" width=\"298\" height=\"199\" \/><\/a><figcaption id=\"caption-attachment-18757\" class=\"wp-caption-text\">Roser Vall\u00e8s, vocal de&#8217;Atenci\u00f3 Prim\u00e0ria del COFB<\/figcaption><\/figure>\n<p>Al voltant d\u2019aquesta q\u00fcesti\u00f3 es va organitzar la sessi\u00f3 \u201cGesti\u00f3 del dolor cr\u00f2nic no oncol\u00f2gic\u201d, que va tenir lloc el passat 2 de desembre al COFB, una reflexi\u00f3 conjunta de diferents especialistes amb punts de vista diversos sobre la gesti\u00f3 del dolor cr\u00f2nic no oncol\u00f2gic. La trobada, impulsada pel Col\u00b7legi conjuntament amb la <a href=\"http:\/\/www.scfarmclin.org\/\" target=\"_blank\" rel=\"noopener\">Societat Catalana de Farm\u00e0cia Cl\u00ednica<\/a> (SCFC) i la <a href=\"http:\/\/www.sefap.org\/\" target=\"_blank\" rel=\"noopener\">Sociedad Espa\u00f1ola de Farmac\u00e9uticos de Atenci\u00f3n Primaria<\/a> (SEFAP), tenia per objectiu donar a con\u00e8ixer l\u2019evid\u00e8ncia cient\u00edfica dels diferents tractaments per gestionar el dolor cr\u00f2nic no oncol\u00f2gic i facilitar l\u2019abordatge del dolor cr\u00f2nic des de l\u2019atenci\u00f3 prim\u00e0ria i quins s\u00f3n els criteris de derivaci\u00f3 a l\u2019especialitzada i de gesti\u00f3. Tamb\u00e9 saber com aborda aquesta patologia la unitat de dolor de l\u2019hospital, quins s\u00f3n els tractaments que prescriu i els criteris de selecci\u00f3 terap\u00e8utics i com la fisioter\u00e0pia pot contribuir a millorar la qualitat de vida del pacient, minvar el dolor o recuperar funcionalment la part del cos afectada.<\/p>\n<p><b><div class=\"box shadow\">Roser Vall\u00e8s, vocal d\u2019Atenci\u00f3 Prim\u00e0ria del COFB<\/b>, i una de les coordinadores de la formaci\u00f3, juntament amb Tom\u00e0s Casas\u00edn (vocal d\u2019Hospitals del COFB), Rosa Madridejos (vocal a Catalunya de SEFAP), Julio Mart\u00ednez Cutillas (president de la SCFC), resumeix els punts m\u00e9s destacats de les intervencions de l\u2019equip docent:<\/p>\n[caption id=\"attachment_18755\" align=\"alignleft\" width=\"298\"]<a href=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2016\/01\/curs-dolor-cronic-no-oncologic-1.jpg\"><img decoding=\"async\" class=\" wp-image-18755   \" alt=\"curs-dolor-cronic-no-oncologic (1)\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2016\/01\/curs-dolor-cronic-no-oncologic-1.jpg\" width=\"298\" height=\"199\" \/><\/a> La farmac\u00e8utica Laura Diego (CedimCat) i la metgessa Esther Lim\u00f3n (EAP Matar\u00f3)[\/caption]\n<p><b>Evid\u00e8ncia cient\u00edfica dels diferents tractaments utilitzats en el tractament del dolor.<\/b> Com a punt de partida, l\u2019evid\u00e8ncia cient\u00edfica sobre com s\u2019ha de fer l\u2019abordatge d\u2019aquest problema de salut, diferent al que es fa amb altres tipus de dolor. Tanmateix <b>Laura Diego<\/b>, farmac\u00e8utica coordinadora del Centre d&#8217;Informaci\u00f3 de Medicaments de Catalunya (CedimCat), va explicar que tenim aspectes pels quals l\u2019evid\u00e8ncia cient\u00edfica encara no t\u00e9 resposta, com seria l\u2019efic\u00e0cia comparada entre els diferents f\u00e0rmacs.<\/p>\n<p><b>Com fa l\u2019abordatge del dolor cr\u00f2nic no oncol\u00f2gic l\u2019atenci\u00f3 prim\u00e0ria? I una unitat de dolor hospital\u00e0ria? <\/b>Aquesta evid\u00e8ncia cient\u00edfica s\u2019aplica en el dia a dia de la consulta d\u2019atenci\u00f3 prim\u00e0ria i de l\u2019atenci\u00f3 especialitzada en les unitats del dolor, com van comentar les metgesses <b>Esther Lim\u00f3n, <\/b>metgessa de fam\u00edlia de l&#8217;EAP Matar\u00f3-7 de l&#8217;ICS, membre del grup ATDOM de la CAMFiC i responsable del grupo de cuidados paliativos de la semFYC, i <b>Maria Vict\u00f2ria Ribera<\/b>, cap de la Unitat de Dolor del Hospital Universitari de la Vall d&#8217;Hebron. Cal, per\u00f2, tenir en compte sempre que <b>el tractament s\u2019ha d\u2019individualitzar i pactar amb cada pacient marcant objectius realistes<\/b> per no crear falses expectatives (la desaparici\u00f3 total del dolor cr\u00f2nic no oncol\u00f2gic en la majoria dels casos \u00e9s pr\u00e0cticament impossible).<\/p>\n[caption id=\"attachment_18759\" align=\"alignright\" width=\"298\"]<a href=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2016\/01\/curs-dolor-cronic-no-oncologic-5.jpg\"><img decoding=\"async\" class=\" wp-image-18759  \" alt=\"curs-dolor-cronic-no-oncologic (5)\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2016\/01\/curs-dolor-cronic-no-oncologic-5.jpg\" width=\"298\" height=\"199\" \/><\/a> La metgessa Maria Vict\u00f2ria Ribera (Hospital Universitari de la Vall d&#8217;Hebron) i la fisioterapeuta Carme S\u00e1nchez (Servei Rehabilitaci\u00f3 de Matar\u00f3)[\/caption]\n<p><b>Abordatge no farmacol\u00f2gic del dolor cr\u00f2nic.<\/b> En aquest abordatge integral s\u00f3n <b>molt importants els tractaments no farmacol\u00f2gics<\/b> i moltes vegades s\u00f3n la soluci\u00f3 del problema. Algunes unitats del dolor tenen integrats psic\u00f2legs i fisioterapeutes que ofereixen tractaments complementaris o a vegades substituts als tractaments farmacol\u00f2gics. Els serveis de rehabilitaci\u00f3 ofereixen instal\u00b7lacions amb equipaments nous que formen part de l\u2019abordatge integral del dolor, tal com va mostrar <b>Carme S\u00e1nchez<\/b>, fisioterapeuta del Servei de Rehabilitaci\u00f3 de Matar\u00f3.<\/p>\n<p>\u201cTots els ponents van coincidir en afirmar que <strong>cal una millora en la coordinaci\u00f3 de tots els serveis que oferim als pacients<\/strong> tenint en compte <strong>tots els nivells assistencials<\/strong>, des de les unitats especialitzades passant per l\u2019atenci\u00f3 prim\u00e0ria i la farm\u00e0cia comunit\u00e0ria. \u00c9s important <strong>individualitzar i adequar el tractament de cada pacient<\/strong> pactant amb ell i fomentant tamb\u00e9 la seva autocura\u201d explica Vall\u00e8s.<b><\/div><\/b><\/p>\n<p>La sessi\u00f3, a la que van assistir farmac\u00e8utics d\u2019atenci\u00f3 prim\u00e0ria, d\u2019hospitals i de l\u2019administraci\u00f3 sanit\u00e0ria, es va poder seguir presencialment o en directe online, via connexi\u00f3 Webinar.<\/p>\n<figure id=\"attachment_18756\" aria-describedby=\"caption-attachment-18756\" style=\"width: 595px\" class=\"wp-caption aligncenter\"><a href=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2016\/01\/curs-dolor-cronic-no-oncologic-2.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\" wp-image-18756  \" alt=\"curs-dolor-cronic-no-oncologic (2)\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2016\/01\/curs-dolor-cronic-no-oncologic-2.jpg\" width=\"595\" height=\"271\" \/><\/a><figcaption id=\"caption-attachment-18756\" class=\"wp-caption-text\">Assistents a la sessi\u00f3 presencial al Col\u00b7legi<\/figcaption><\/figure>\n<p align=\"right\"><b>Amb la col\u00b7laboraci\u00f3 de:<\/b><\/p>\n<p align=\"right\"><b><a href=\"http:\/\/www.esteve.es\/EsteveFront\/EST.do\" target=\"_blank\" rel=\"noopener\"><img loading=\"lazy\" decoding=\"async\" class=\"alignright  wp-image-5489\" alt=\"esteve\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2014\/02\/esteve.jpg\" width=\"152\" height=\"59\" \/><\/a><\/b><\/p>\n","protected":false},"excerpt":{"rendered":"<p>El dolor est\u00e0 entre els primers trastorns cr\u00f2nics declarats per la poblaci\u00f3, amb afectaci\u00f3 important de la qualitat de vida de les persones que el pateixen. La prevalen\u00e7a del dolor cr\u00f2nic en la poblaci\u00f3 adulta a l\u2019estat espanyol \u00e9s del 23,4% i superior en les dones i en el grup [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":18758,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[57],"tags":[2307,938,2308,480],"class_list":["post-18752","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-mon-collegial","tag-abordatge-terapeutic","tag-atencio-primaria","tag-dolor-cronic","tag-farmacia-hospitalaria"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Cap a una millor gesti\u00f3 del dolor cr\u00f2nic no oncol\u00f2gic - Col\u00b7legi de Farmac\u00e8utics de Barcelona<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/novaorg.cofb.net\/2016\/02\/03\/cap-a-una-millor-gestio-del-dolor-cronic-oncologic\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cap a una millor gesti\u00f3 del dolor cr\u00f2nic no oncol\u00f2gic - Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"og:description\" content=\"El dolor est\u00e0 entre els primers trastorns cr\u00f2nics declarats per la poblaci\u00f3, amb afectaci\u00f3 important de la qualitat de vida de les persones que el pateixen. La prevalen\u00e7a del dolor cr\u00f2nic en la poblaci\u00f3 adulta a l\u2019estat espanyol \u00e9s del 23,4% i superior en les dones i en el grup [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/novaorg.cofb.net\/2016\/02\/03\/cap-a-una-millor-gestio-del-dolor-cronic-oncologic\/\" \/>\n<meta property=\"og:site_name\" content=\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\" \/>\n<meta property=\"article:published_time\" content=\"2016-02-03T12:54:25+00:00\" \/>\n<meta name=\"author\" content=\"wpAdminCofbOrg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:site\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"wpAdminCofbOrg\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minuts\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/02\/03\/cap-a-una-millor-gestio-del-dolor-cronic-oncologic\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/02\/03\/cap-a-una-millor-gestio-del-dolor-cronic-oncologic\/\"},\"author\":{\"name\":\"wpAdminCofbOrg\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\"},\"headline\":\"Cap a una millor gesti\u00f3 del dolor cr\u00f2nic no oncol\u00f2gic\",\"datePublished\":\"2016-02-03T12:54:25+00:00\",\"dateModified\":\"2016-02-03T12:54:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/02\/03\/cap-a-una-millor-gestio-del-dolor-cronic-oncologic\/\"},\"wordCount\":959,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/02\/03\/cap-a-una-millor-gestio-del-dolor-cronic-oncologic\/#primaryimage\"},\"thumbnailUrl\":\"\",\"keywords\":[\"abordatge terap\u00e8utic\",\"Atenci\u00f3 prim\u00e0ria\",\"dolor cr\u00f2nic\",\"farm\u00e0cia hospital\u00e0ria\"],\"articleSection\":[\"M\u00f3n col\u00b7legial\"],\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/novaorg.cofb.net\/2016\/02\/03\/cap-a-una-millor-gestio-del-dolor-cronic-oncologic\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/02\/03\/cap-a-una-millor-gestio-del-dolor-cronic-oncologic\/\",\"url\":\"https:\/\/novaorg.cofb.net\/2016\/02\/03\/cap-a-una-millor-gestio-del-dolor-cronic-oncologic\/\",\"name\":\"Cap a una millor gesti\u00f3 del dolor cr\u00f2nic no oncol\u00f2gic - Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/02\/03\/cap-a-una-millor-gestio-del-dolor-cronic-oncologic\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/02\/03\/cap-a-una-millor-gestio-del-dolor-cronic-oncologic\/#primaryimage\"},\"thumbnailUrl\":\"\",\"datePublished\":\"2016-02-03T12:54:25+00:00\",\"dateModified\":\"2016-02-03T12:54:25+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/02\/03\/cap-a-una-millor-gestio-del-dolor-cronic-oncologic\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/novaorg.cofb.net\/2016\/02\/03\/cap-a-una-millor-gestio-del-dolor-cronic-oncologic\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/02\/03\/cap-a-una-millor-gestio-del-dolor-cronic-oncologic\/#primaryimage\",\"url\":\"\",\"contentUrl\":\"\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/02\/03\/cap-a-una-millor-gestio-del-dolor-cronic-oncologic\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/novaorg.cofb.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cap a una millor gesti\u00f3 del dolor cr\u00f2nic no oncol\u00f2gic\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cofb.org\/#website\",\"url\":\"https:\/\/www.cofb.org\/\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cofb.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"ca\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cofb.org\/#organization\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"url\":\"https:\/\/www.cofb.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"width\":500,\"height\":105,\"caption\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\",\"https:\/\/twitter.com\/farmaceuticsbcn\",\"https:\/\/www.instagram.com\/farmaceuticsbcn\/\",\"https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\",\"name\":\"wpAdminCofbOrg\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"caption\":\"wpAdminCofbOrg\"},\"sameAs\":[\"http:\/\/192.168.64.122\/wordpress\"],\"url\":\"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cap a una millor gesti\u00f3 del dolor cr\u00f2nic no oncol\u00f2gic - Col\u00b7legi de Farmac\u00e8utics de Barcelona","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/novaorg.cofb.net\/2016\/02\/03\/cap-a-una-millor-gestio-del-dolor-cronic-oncologic\/","og_locale":"ca_ES","og_type":"article","og_title":"Cap a una millor gesti\u00f3 del dolor cr\u00f2nic no oncol\u00f2gic - Col\u00b7legi de Farmac\u00e8utics de Barcelona","og_description":"El dolor est\u00e0 entre els primers trastorns cr\u00f2nics declarats per la poblaci\u00f3, amb afectaci\u00f3 important de la qualitat de vida de les persones que el pateixen. La prevalen\u00e7a del dolor cr\u00f2nic en la poblaci\u00f3 adulta a l\u2019estat espanyol \u00e9s del 23,4% i superior en les dones i en el grup [&hellip;]","og_url":"https:\/\/novaorg.cofb.net\/2016\/02\/03\/cap-a-una-millor-gestio-del-dolor-cronic-oncologic\/","og_site_name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","article_publisher":"https:\/\/www.facebook.com\/farmaceuticsbcn\/","article_published_time":"2016-02-03T12:54:25+00:00","author":"wpAdminCofbOrg","twitter_card":"summary_large_image","twitter_creator":"@farmaceuticsbcn","twitter_site":"@farmaceuticsbcn","twitter_misc":{"Escrit per":"wpAdminCofbOrg","Temps estimat de lectura":"5 minuts"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/novaorg.cofb.net\/2016\/02\/03\/cap-a-una-millor-gestio-del-dolor-cronic-oncologic\/#article","isPartOf":{"@id":"https:\/\/novaorg.cofb.net\/2016\/02\/03\/cap-a-una-millor-gestio-del-dolor-cronic-oncologic\/"},"author":{"name":"wpAdminCofbOrg","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb"},"headline":"Cap a una millor gesti\u00f3 del dolor cr\u00f2nic no oncol\u00f2gic","datePublished":"2016-02-03T12:54:25+00:00","dateModified":"2016-02-03T12:54:25+00:00","mainEntityOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2016\/02\/03\/cap-a-una-millor-gestio-del-dolor-cronic-oncologic\/"},"wordCount":959,"commentCount":0,"publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2016\/02\/03\/cap-a-una-millor-gestio-del-dolor-cronic-oncologic\/#primaryimage"},"thumbnailUrl":"","keywords":["abordatge terap\u00e8utic","Atenci\u00f3 prim\u00e0ria","dolor cr\u00f2nic","farm\u00e0cia hospital\u00e0ria"],"articleSection":["M\u00f3n col\u00b7legial"],"inLanguage":"ca","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/novaorg.cofb.net\/2016\/02\/03\/cap-a-una-millor-gestio-del-dolor-cronic-oncologic\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/novaorg.cofb.net\/2016\/02\/03\/cap-a-una-millor-gestio-del-dolor-cronic-oncologic\/","url":"https:\/\/novaorg.cofb.net\/2016\/02\/03\/cap-a-una-millor-gestio-del-dolor-cronic-oncologic\/","name":"Cap a una millor gesti\u00f3 del dolor cr\u00f2nic no oncol\u00f2gic - Col\u00b7legi de Farmac\u00e8utics de Barcelona","isPartOf":{"@id":"https:\/\/www.cofb.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2016\/02\/03\/cap-a-una-millor-gestio-del-dolor-cronic-oncologic\/#primaryimage"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2016\/02\/03\/cap-a-una-millor-gestio-del-dolor-cronic-oncologic\/#primaryimage"},"thumbnailUrl":"","datePublished":"2016-02-03T12:54:25+00:00","dateModified":"2016-02-03T12:54:25+00:00","breadcrumb":{"@id":"https:\/\/novaorg.cofb.net\/2016\/02\/03\/cap-a-una-millor-gestio-del-dolor-cronic-oncologic\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/novaorg.cofb.net\/2016\/02\/03\/cap-a-una-millor-gestio-del-dolor-cronic-oncologic\/"]}]},{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/novaorg.cofb.net\/2016\/02\/03\/cap-a-una-millor-gestio-del-dolor-cronic-oncologic\/#primaryimage","url":"","contentUrl":""},{"@type":"BreadcrumbList","@id":"https:\/\/novaorg.cofb.net\/2016\/02\/03\/cap-a-una-millor-gestio-del-dolor-cronic-oncologic\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/novaorg.cofb.net\/"},{"@type":"ListItem","position":2,"name":"Cap a una millor gesti\u00f3 del dolor cr\u00f2nic no oncol\u00f2gic"}]},{"@type":"WebSite","@id":"https:\/\/www.cofb.org\/#website","url":"https:\/\/www.cofb.org\/","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"","publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cofb.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"ca"},{"@type":"Organization","@id":"https:\/\/www.cofb.org\/#organization","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","url":"https:\/\/www.cofb.org\/","logo":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","width":500,"height":105,"caption":"Col\u00b7legi de Farmac\u00e8utics de Barcelona"},"image":{"@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/farmaceuticsbcn\/","https:\/\/twitter.com\/farmaceuticsbcn","https:\/\/www.instagram.com\/farmaceuticsbcn\/","https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/"]},{"@type":"Person","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb","name":"wpAdminCofbOrg","image":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","caption":"wpAdminCofbOrg"},"sameAs":["http:\/\/192.168.64.122\/wordpress"],"url":"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/"}]}},"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"trp-custom-language-flag":false},"uagb_author_info":{"display_name":"wpAdminCofbOrg","author_link":"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/"},"uagb_comment_info":0,"uagb_excerpt":"El dolor est\u00e0 entre els primers trastorns cr\u00f2nics declarats per la poblaci\u00f3, amb afectaci\u00f3 important de la qualitat de vida de les persones que el pateixen. La prevalen\u00e7a del dolor cr\u00f2nic en la poblaci\u00f3 adulta a l\u2019estat espanyol \u00e9s del 23,4% i superior en les dones i en el grup [&hellip;]","_links":{"self":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/18752","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/comments?post=18752"}],"version-history":[{"count":0,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/18752\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/"}],"wp:attachment":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/media?parent=18752"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/categories?post=18752"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/tags?post=18752"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}